Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b9196f0e8f24b99d18c2b3082c33e5f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2019-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdf2d22972f54eac1e9ff3d8824c35f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b05bbe87047e7bfe90fc09939ad21427 |
publicationDate |
2019-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-110241214-A |
titleOfInvention |
Application of the LOC100505874 in the early diagnosis of larynx squamous carcinoma |
abstract |
The present invention provides purposes of the LOC100505874 as the molecular marker of diagnosis larynx squamous carcinoma.It is of the invention research shows that expression of the LOC100505874 in larynx squamous cell carcinoma patients cancerous tissue and cancer beside organism there are significant differences, think that LOC100505874 can be used as the molecular marker of diagnosis larynx squamous carcinoma accordingly.The product that can be used for early diagnosing larynx squamous carcinoma is developed according to the studies above achievement, the product recall rate is good, is suitble in clinical expansion. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111733249-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110229906-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111647659-A |
priorityDate |
2019-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |